These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 15686598)

  • 41. Consequences of slow Wallerian degeneration for regenerating motor and sensory axons.
    Brown MC; Lunn ER; Perry VH
    J Neurobiol; 1992 Jul; 23(5):521-36. PubMed ID: 1431835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage-specific RhoA knockout delays Wallerian degeneration after peripheral nerve injury in mice.
    Xu J; Wen J; Fu L; Liao L; Zou Y; Zhang J; Deng J; Zhang H; Liu J; Wang X; Zuo D; Guo J
    J Neuroinflammation; 2021 Oct; 18(1):234. PubMed ID: 34654444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
    Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
    Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Motor axon excitability during Wallerian degeneration.
    Moldovan M; Alvarez S; Krarup C
    Brain; 2009 Feb; 132(Pt 2):511-23. PubMed ID: 19074190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.
    Beirowski B; Babetto E; Gilley J; Mazzola F; Conforti L; Janeckova L; Magni G; Ribchester RR; Coleman MP
    J Neurosci; 2009 Jan; 29(3):653-68. PubMed ID: 19158292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Axon degeneration: where the Wlds things are.
    Wang JT; Barres BA
    Curr Biol; 2012 Apr; 22(7):R221-3. PubMed ID: 22497934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axon degeneration mechanisms: commonality amid diversity.
    Coleman M
    Nat Rev Neurosci; 2005 Nov; 6(11):889-98. PubMed ID: 16224497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Motor neuron death induced by axotomy in neonatal mice occurs more slowly in a mutant strain in which Wallerian degeneration is very slow.
    Lapper SR; Brown MC; Perry VH
    Eur J Neurosci; 1994 Mar; 6(3):473-7. PubMed ID: 8019683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resveratrol abolishes resistance to axonal degeneration in slow Wallerian degeneration (WldS) mice: activation of SIRT2, an NAD-dependent tubulin deacetylase.
    Suzuki K; Koike T
    Biochem Biophys Res Commun; 2007 Aug; 359(3):665-71. PubMed ID: 17560549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology.
    Murray LM; Thomson D; Conklin A; Wishart TM; Gillingwater TH
    J Anat; 2008 Dec; 213(6):633-45. PubMed ID: 19094180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of the compound action potential: an electrophysiological, biochemical and morphological study of early events in axonal degeneration in the C57BL/Ola mouse.
    Tsao JW; Brown MC; Carden MJ; McLean WG; Perry VH
    Eur J Neurosci; 1994 Apr; 6(4):516-24. PubMed ID: 8025707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combining CUBIC Optical Clearing and Thy1-YFP-16 Mice to Observe Morphological Axon Changes During Wallerian Degeneration.
    Yuan YS; Yu F; Niu SP; Lu H; Kou YH; Xu HL
    Curr Med Sci; 2021 Oct; 41(5):944-952. PubMed ID: 34693494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse.
    Coleman MP; Conforti L; Buckmaster EA; Tarlton A; Ewing RM; Brown MC; Lyon MF; Perry VH
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9985-90. PubMed ID: 9707587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
    Conforti L; Gilley J; Coleman MP
    Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
    Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
    J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.
    Parson SH; Ribchester RR; Davie N; Gandhi NP; Malik RQ; Gillingwater TH; Thomson D
    J Neurosci Res; 2004 Apr; 76(1):64-75. PubMed ID: 15048930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity.
    O'Donnell KC; Lulla A; Stahl MC; Wheat ND; Bronstein JM; Sagasti A
    Dis Model Mech; 2014 May; 7(5):571-82. PubMed ID: 24626988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo imaging of injured cortical axons reveals a rapid onset form of Wallerian degeneration.
    Canty AJ; Jackson JS; Huang L; Trabalza A; Bass C; Little G; Tortora M; Khan S; De Paola V
    BMC Biol; 2020 Nov; 18(1):170. PubMed ID: 33208154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Drama of Wallerian Degeneration: The Cast, Crew, and Script.
    Zhang K; Jiang M; Fang Y
    Annu Rev Genet; 2021 Nov; 55():93-113. PubMed ID: 34351802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging.
    Xie M; Wang Q; Wu TH; Song SK; Sun SW
    Neuroscience; 2011 Dec; 197():339-47. PubMed ID: 21964470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.